Skip to main content
Clinical Trials/NCT04259073
NCT04259073
Completed
Not Applicable

Does Pregabalin Improve Post-operative Pain After C-section Delivery

Hôpital Universitaire Fattouma Bourguiba1 site in 1 country138 target enrollmentMarch 1, 2018

Overview

Phase
Not Applicable
Intervention
Placebos
Conditions
Postoperative Pain
Sponsor
Hôpital Universitaire Fattouma Bourguiba
Enrollment
138
Locations
1
Primary Endpoint
Time to first analgesic request
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Pregabalin due to its antihyperalgesic effect, has proven its efficacy on neuropathic pain, essentially in nociceptive surgeries. Few studies have attempted to identify the utility of pregabalin as a premedication before cesarean delivery.

The investigators aimed to determine whether or not pregabalin as premedication improves analgesia post cesarean delivery.

Detailed Description

The investigators conducted a controlled, randomised, prospective and double-blind trial. One hundred thirty eight participants were included, with American Society of Anesthesiologists physical status classification of I to II, with pregnancies of at least 36 weeks of gestation who were scheduled for elective caesarean delivery under spinal anaesthesia. One hour before induction of anaesthesia participants received a capsule containing sugar placebo (placebo group), pregabalin 150 mg or pregabalin 300 mg. Data related to surgical history, pre-existing medical problems, indications for cesarean and peroperative hemodynamic changes were analyzed. The primary outcome was first analgesic request. Secondary outcomes included maternal pain scores at rest and during movement, rescue analgesics consumption, sedation, nausea, vomiting, pruritus and Apgar scores. All maternal secondary outcome variables were recorded 0, 2, 4, 6, 12, 18, and 24 h after delivery. Common side effects linked to pregabalin such as somnolence, blurred or abnormal vision, or fetal distress were collected.

Registry
clinicaltrials.gov
Start Date
March 1, 2018
End Date
October 10, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Sequential
Sex
Female

Investigators

Sponsor
Hôpital Universitaire Fattouma Bourguiba
Responsible Party
Principal Investigator
Principal Investigator

Khemili Malek

Principal investigator

Hôpital Universitaire Fattouma Bourguiba

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists class I or II
  • single pregnancies at term
  • under spinal anesthesia

Exclusion Criteria

  • conversion to general anesthesia
  • post partum hemorrhage requiring specific resuscitation
  • local anesthetic toxicity
  • violation of the protocol

Arms & Interventions

Group C

two capsules filled with sugar

Intervention: Placebos

Group P150

two capsules; one of them containing sugar (like the placebo one), the other is the active drug (pregabalin 150 mg)

Intervention: Pregabalin 150mg

Group P300

two capsules of pregabalin (150 mg)

Intervention: Pregabalin 300mg

Outcomes

Primary Outcomes

Time to first analgesic request

Time Frame: 24 hours

in minutes, the time between the end of the operation to the first demand of analgesics

Secondary Outcomes

  • Visual disturbances(24 hours post operatively)
  • Visual analog scale (VAS) at rest and movement(24 hours)
  • Maternal satisfaction(24 hours)
  • Heart rate(Per operative period)
  • Maternal consumption of paracetamol postoperatively(24 hours)
  • Ramsay score for sedation(24 hours post operatively)
  • Apgar scores(1 and 5 minutes after birth)
  • Non-invasive blood pressure(Per operative period)
  • Fluids administered to the mother per operatively(Per operative period)
  • Dose of ephedrine administered to the mother per operatively(Per operative period)

Study Sites (1)

Loading locations...

Similar Trials